文献速递儿科与产科急症重症综合管理与镇静镇痛

围存活期剖宫产分娩的母体结局

Maternal Outcomes Among Periviable Births by Cesarean Delivery.
PubMed 文献 · JAMA Netw Open · 2026-09-01
一句话结论围存活期(22周0天至25周6天)剖宫产较阴道分娩与母体不良结局风险升高相关,包括非输血严重母体发病率、输血、危重症复合结局和静脉血栓栓塞。

该横断面研究分析美国国家住院样本2016-2022年98 240例围存活期单胎分娩住院,其中39 595例(40.3%)为剖宫产。剖宫产率随孕周增加而上升(22周13.1%至25周54.8%),且与既往剖宫产、妊娠期高血压疾病及城市教学医院相关。校正后剖宫产与非输血严重母体发病率(AOR 2.50)、输血(AOR 2.44)、危重症复合结局(AOR 3.41)和静脉血栓栓塞(AOR 2.44)风险升高相关。研究期间剖宫产比例显著增加(AAPC 1.6%)。

要点

  • 围存活期剖宫产率随孕周增加:22周0-6天13.1%,23周37.4%,24周52.1%,25周54.8%。
  • 剖宫产与危重症复合结局风险升高相关(AOR 3.41;95%CI 2.25-5.17)。
  • 剖宫产与非输血严重母体发病率(AOR 2.50;95%CI 2.10-2.97)和输血(AOR 2.44;95%CI 2.03-2.94)风险升高相关。
  • 既往剖宫产(AOR 2.57)和妊娠期高血压疾病(AOR 3.19)与剖宫产几率升高相关。
  • 研究期间围存活期剖宫产比例显著增加(AAPC 1.6%;95%CI 0.7%-2.4%)。

适用人群与场景

  • 美国国家住院样本中2016-2022年单胎围存活期(22周0天至25周6天)分娩住院患者。
  • 排除人群原文未提及。

诊断标准与关键阈值

  • 围存活期定义为孕22周0天至25周6天。
  • 暴露为剖宫产 vs 阴道分娩。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:横断面研究,使用美国国家住院样本7年数据(2016-2022),估计98 240例围存活期分娩,其中剖宫产39 595例(40.3%),阴道分娩58 645例(59.7%)。
  • 剖宫产率随孕周增加:22周0-6天13.1%,23周0-6天37.4%,24周0-6天52.1%,25周0-6天54.8%。
  • 与剖宫产几率升高相关的因素:既往剖宫产(AOR 2.57;95%CI 2.35-2.82)、妊娠期高血压疾病(AOR 3.19;95%CI 2.88-3.53)、城市教学医院 vs 农村医院(AOR 1.49;95%CI 1.26-1.76)。
  • 与剖宫产几率降低相关的因素:胎儿生长受限(AOR 0.47;95%CI 0.42-0.53)、 preterm premature rupture of membranes(AOR 0.50;95%CI 0.46-0.54)、早产临产(AOR 0.79;95%CI 0.68-0.91)。
  • 与阴道分娩相比,剖宫产校正后与非输血严重母体发病率(AOR 2.50;95%CI 2.10-2.97)、输血(AOR 2.44;95%CI 2.03-2.94)、危重症复合结局(AOR 3.41;95%CI 2.25-5.17)、静脉血栓栓塞(AOR 2.44;95%CI 1.27-4.70)风险升高相关。
  • 趋势分析:围存活期剖宫产比例显著增加(AAPC 1.6%;95%CI 0.7%-2.4%)。

证据类型、等级与局限

  • 证据类型:横断面研究。
  • 局限:观察性设计,不能推断因果关系;原文未提及其他局限。

对床旁实践的改变

  • 围存活期剖宫产与母体不良结局风险升高相关, counselled 患者时应告知此风险。
  • 剖宫产率随孕周增加而上升,临床决策需考虑孕周。
  • 既往剖宫产和妊娠期高血压疾病增加剖宫产几率,胎儿生长受限、preterm premature rupture of membranes和早产临产降低剖宫产几率。
  • 研究期间剖宫产比例增加,提示临床实践变化。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

IMPORTANCE: Contemporary estimates of adverse maternal outcomes associated with periviable cesarean delivery are important for patient counseling and clinical decision-making.

OBJECTIVE: To characterize trends, risks factors, and adverse maternal outcomes associated with periviable cesarean delivery at 22 weeks 0 days to 25 weeks 6 days of gestation.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study analyzed adverse maternal outcomes among singleton periviable delivery hospitalizations at 22 weeks 0 days to 25 weeks 6 days' gestational age (GA). Hospitalizations were identified using the US National Inpatient Sample for a 7-year period (2016-2022). Data analysis was performed between March and December 2025.

EXPOSURES: The exposure of interest was periviable vaginal vs cesarean delivery. Clinical, demographic, and hospital factors associated with periviable cesarean delivery were also analyzed.

MAIN OUTCOMES AND MEASURES: The primary end point was risk for a range of adverse maternal outcomes, including nontransfusion severe maternal morbidity, transfusion, a critical care composite, a wound complications composite, venous thromboembolism, postpartum hemorrhage, endometritis, and peripartum hysterectomy. Unadjusted and adjusted logistic regression models for adverse outcomes were performed. Regression estimates were presented as unadjusted and adjusted odds ratios (AOR) with 95% CIs and as adjusted prevalence differences with 95% CIs. Trends were analyzed using joinpoint regression, and estimates were presented as the average annual percent change (AAPC).

RESULTS: Of an estimated 98 240 periviable deliveries identified, 39 595 (40.3%) were by cesarean delivery (median [IQR] maternal age, 29.9 [24.1-33.4] years) and 58 645 (59.7%) were by vaginal delivery (median [IQR] maternal age, 28.2 [23.3-32.9] years). Cesarean delivery rates increased with advancing GA (13.1% of births at 22 weeks 0 days to 22 weeks 6 days; 37.4% of births at 23 weeks 0 days to 23 weeks 6 days; 52.1 % of births at 24 weeks 0 days to 24 weeks 6 days; 54.8% of births at 25 weeks 0 days to 25 weeks 6 days) and were more common in the setting of a prior cesarean delivery (AOR, 2.57; 95% CI, 2.35-2.82) or hypertensive disorder of pregnancy (AOR, 3.19; 95% CI, 2.88-3.53), and at urban teaching hospitals vs rural hospitals (AOR, 1.49; 95% CI, 1.26-1.76). Cesarean delivery was less likely in the setting of fetal growth restriction (AOR, 0.47; 95% CI, 0.42-0.53), preterm premature rupture of membranes (AOR, 0.50; 95% CI, 0.46-0.54), and preterm labor (AOR, 0.79; 95% CI, 0.68-0.91). Sensitivity analyses incorporating indication for cesarean delivery yielded similar results. Compared with vaginal delivery, cesarean delivery was associated with increased adjusted odds of nontransfusion severe maternal morbidity (AOR, 2.50; 95% CI, 2.10-2.97), transfusion (AOR, 2.44; 95% CI, 2.03-2.94), a critical care composite (AOR, 3.41; 95% CI, 2.25-5.17), and venous thromboembolism (AOR, 2.44; 95% CI, 1.27-4.70). In trends analysis, the proportion of periviable deliveries occurring by cesarean delivery increased significantly over the study period (AAPC, 1.6%; 95% CI, 0.7%-2.4%).

CONCLUSIONS AND RELEVANCE: In this cross-sectional study of periviable births, the proportion of periviable deliveries by cesarean increased over time. Compared with vaginal delivery, periviable cesarean delivery was associated with an increased risk for adverse maternal outcomes and severe maternal morbidity.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Trahan MJ, Wen T, Huang Y, et al. Maternal Outcomes Among Periviable Births by Cesarean Delivery. JAMA Netw Open. 2026. PMID: 42758508. doi:10.1001/jamanetworkopen.2026.34705

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。